Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,890 | 248 | 99.7% |
| Education | $18.27 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,427 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,070 | 48 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $508.60 | 18 | $0 (2024) |
| Lilly USA, LLC | $466.02 | 30 | $0 (2024) |
| Amgen Inc. | $415.62 | 15 | $0 (2024) |
| PFIZER INC. | $402.27 | 15 | $0 (2024) |
| Novo Nordisk Inc | $205.85 | 5 | $0 (2023) |
| Merck Sharp & Dohme LLC | $144.35 | 9 | $0 (2024) |
| Horizon Pharma plc | $140.13 | 4 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $138.19 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,189 | 49 | AstraZeneca Pharmaceuticals LP ($406.93) |
| 2023 | $937.35 | 41 | AstraZeneca Pharmaceuticals LP ($457.14) |
| 2022 | $781.99 | 35 | AstraZeneca Pharmaceuticals LP ($218.12) |
| 2021 | $804.35 | 45 | AstraZeneca Pharmaceuticals LP ($174.83) |
| 2020 | $394.52 | 26 | Lilly USA, LLC ($121.76) |
| 2019 | $544.79 | 15 | AstraZeneca Pharmaceuticals LP ($115.42) |
| 2018 | $491.06 | 15 | Horizon Pharma plc ($118.79) |
| 2017 | $764.34 | 24 | Novartis Pharmaceuticals Corporation ($308.65) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $39.04 | General |
| Category: WOMENS HEALTH | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $119.69 | General |
| Category: Cardiology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Respiratory | ||||||
| 09/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Gastroenterology | ||||||
| 09/10/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: HEMATOLOGY | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.31 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: WOMENS HEALTH | ||||||
| 08/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Inflammation | ||||||
| 08/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes Care | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: PAIN | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/18/2024 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: HEMATOLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 737 | 1,614 | $277,415 | $139,469 |
| 2022 | 14 | 983 | 2,133 | $355,411 | $177,348 |
| 2021 | 17 | 1,299 | 3,626 | $555,732 | $283,848 |
| 2020 | 18 | 1,677 | 6,272 | $931,765 | $484,875 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 202 | 638 | $79,112 | $39,144 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 67 | 285 | $57,250 | $35,932 | 62.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 117 | 258 | $45,924 | $23,847 | 51.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 109 | 139 | $46,982 | $18,640 | 39.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 142 | 173 | $31,832 | $15,193 | 47.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 47 | 50 | $11,500 | $4,949 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 38 | $3,990 | $1,487 | 37.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 33 | $825.00 | $277.20 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 349 | $70,150 | $46,868 | 66.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 235 | 722 | $89,528 | $40,390 | 45.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 197 | 405 | $72,090 | $32,546 | 45.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 120 | 142 | $47,996 | $22,074 | 46.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 127 | 143 | $26,312 | $11,719 | 44.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 43 | $9,890 | $4,388 | 44.4% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 15 | 55 | $6,215 | $3,957 | 63.7% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 14 | 72 | $6,120 | $3,618 | 59.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 21 | $7,820 | $3,610 | 46.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 69 | $7,245 | $2,965 | 40.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 15 | 19 | $3,909 | $2,384 | 61.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $5,120 | $2,023 | 39.5% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $1,441 | $619.04 | 43.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 45 | 63 | $1,575 | $186.78 | 11.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 346 | 1,277 | $158,348 | $72,911 | 46.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 223 | 622 | $110,716 | $50,907 | 46.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 80 | 321 | $64,600 | $43,926 | 68.0% |
About Dr. Raphael Agada, MD
Dr. Raphael Agada, MD is a Internal Medicine healthcare provider based in Petersburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205835725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Agada, MD has received a total of $5,908 in payments from pharmaceutical and medical device companies, with $1,189 received in 2024. These payments were reported across 250 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,890).
As a Medicare-enrolled provider, Agada has provided services to 4,696 Medicare beneficiaries, totaling 13,645 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Petersburg, VA
- Active Since 07/18/2005
- Last Updated 02/09/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205835725
Products in Payments
- TRELEGY ELLIPTA (Drug) $797.77
- BREZTRI (Drug) $589.66
- ENTRESTO (Drug) $508.60
- FARXIGA (Drug) $406.85
- AIRSUPRA (Drug) $247.01
- NURTEC ODT (Drug) $214.59
- Otezla (Drug) $181.99
- TRULICITY (Drug) $156.09
- Repatha (Biological) $146.61
- EMGALITY (Drug) $137.93
- ELIQUIS (Drug) $134.21
- OXBRYTA (Drug) $124.97
- INCRUSE (Drug) $118.72
- XIFAXAN (Drug) $118.58
- PRIMARY CARE - DISEASE STATE (Drug) $108.93
- JARDIANCE (Drug) $106.19
- Saxenda (Drug) $99.73
- VERQUVO (Drug) $96.67
- ANORO ELLIPTA (Drug) $96.64
- SOLIQUA (Drug) $96.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Petersburg
Sajid Naveed, Md, MD
Internal Medicine — Payments: $9,344
Nishanth Sukumaran, Md, MD
Internal Medicine — Payments: $6,306
Dr. Lerla Joseph, M.d, M.D
Internal Medicine — Payments: $5,815
Dr. Stephen Thompson, D.o, D.O
Internal Medicine — Payments: $5,205
Benjamin Leslie, D.o, D.O
Internal Medicine — Payments: $4,891
Dr. Caroline Armstrong, D.o, D.O
Internal Medicine — Payments: $4,834